Skip to main content
. 2021 Jun 18;30:09636897211024183. doi: 10.1177/09636897211024183

Figure 4.

Figure 4.

Evans Blue assay demonstrates the suppression of BBB permeability by the administration of hAMSCs. (a) Representative images of whole brain (left column) and coronal sections (middle and right columns). EB deposited in the brain parenchyma of the ischemic core and the peri-infarct area (middle cerebral artery territory of the left hemisphere), where the BBB was disrupted. Scale bar: 5 mm. (b) Quantitative analysis of EB content [M-high: n = 8; M-vehi: n = 8]. *; P < .01, unpaired t-test.